Clinical Heterogeneity and Different Phenotypes in Patients with
LLS
Luscan–Lumish syndrome
MRD70
RAPAS
Rabin–Pappas syndrome
SETD2
autism spectrum disorder
autosomal dominant 70
intellectual developmental disorder
intellectual disability
overgrowth
Journal
Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097
Informations de publication
Date de publication:
29 05 2023
29 05 2023
Historique:
received:
11
05
2023
revised:
25
05
2023
accepted:
26
05
2023
medline:
29
6
2023
pubmed:
28
6
2023
entrez:
28
6
2023
Statut:
epublish
Résumé
SETD2 belongs to the family of histone methyltransferase proteins and has been associated with three nosologically distinct entities with different clinical and molecular features: Luscan-Lumish syndrome (LLS), intellectual developmental disorder, autosomal dominant 70 (MRD70), and Rabin-Pappas syndrome (RAPAS). LLS [MIM #616831] is an overgrowth disorder with multisystem involvement including intellectual disability, speech delay, autism spectrum disorder (ASD), macrocephaly, tall stature, and motor delay. RAPAS [MIM #6201551] is a recently reported multisystemic disorder characterized by severely impaired global and intellectual development, hypotonia, feeding difficulties with failure to thrive, microcephaly, and dysmorphic facial features. Other neurologic findings may include seizures, hearing loss, ophthalmologic defects, and brain imaging abnormalities. There is variable involvement of other organ systems, including skeletal, genitourinary, cardiac, and potentially endocrine. Three patients who carried the missense variant p.Arg1740Gln in
Identifiants
pubmed: 37372360
pii: genes14061179
doi: 10.3390/genes14061179
pmc: PMC10297832
pii:
doi:
Substances chimiques
SETD2 protein, human
EC 2.1.1.43
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Nature. 2012 Apr 04;485(7397):246-50
pubmed: 22495309
Clin Genet. 2019 Jun;95(6):726-731
pubmed: 30628072
Cell. 2016 Aug 11;166(4):950-962
pubmed: 27518565
J Biol Chem. 2005 Oct 21;280(42):35261-71
pubmed: 16118227
Anticancer Res. 2010 Sep;30(9):3309-11
pubmed: 20944102
Am J Med Genet A. 2018 May;176(5):1212-1215
pubmed: 29681085
Eur J Hum Genet. 2020 Apr;28(4):469-479
pubmed: 31685998
J Autism Dev Disord. 2015 Nov;45(11):3764-70
pubmed: 26084711
Protein Sci. 2021 Jan;30(1):70-82
pubmed: 32881101
Am J Med Genet A. 2020 Sep;182(9):2037-2048
pubmed: 32710489
J Clin Endocrinol Metab. 2021 Mar 8;106(3):718-723
pubmed: 33248444
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Science. 2012 Dec 21;338(6114):1619-22
pubmed: 23160955
Gene Ther. 2018 Sep;25(6):439-449
pubmed: 29941984
Nat Commun. 2021 Jul 5;12(1):4113
pubmed: 34226540
Int J Mol Sci. 2019 Feb 27;20(5):
pubmed: 30818762
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
Front Genet. 2023 Mar 21;14:1153284
pubmed: 37025455
Nucleic Acids Res. 2022 Jan 7;50(D1):D439-D444
pubmed: 34791371
J Med Genet. 2016 Nov;53(11):743-751
pubmed: 27317772
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Elife. 2014 May 06;3:e02482
pubmed: 24843002
Eur J Med Genet. 2021 May;64(5):104200
pubmed: 33766796
Am J Med Genet C Semin Med Genet. 2005 Aug 15;137C(1):53-71
pubmed: 16010678
Am J Med Genet C Semin Med Genet. 2019 Dec;181(4):509-518
pubmed: 31643139
J Med Genet. 2014 Aug;51(8):512-7
pubmed: 24852293
Oncogene. 2015 Nov 12;34(46):5699-708
pubmed: 25728682
Protein Sci. 2018 Jan;27(1):14-25
pubmed: 28710774
Sci Adv. 2021 Jan 1;7(1):
pubmed: 33523829